drugset
drugset / Trial / NCT05850208

Autologous Bone Marrow Mesenchymal Stem Cells (BMSCs) Transplantation in the Treatment of Ischemic Stroke

NCT05850208 ↗

Phase 1 Unknown 60 enrolled Zhujiang Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is to evaluated the safety and efficacy of BMSCs transplantation in the treatment of ischemic stroke, so as to provide a basis for future clinical application of BMSCs transplantation in the treatment of ischemic stroke.

Timeline

Start
2022-02-23
Primary completion
2024-11-30
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject BMSCs Cell therapy 1e+06 cells/kg Intravenous

Indications

ischemic stroke